Translate page

English English
en Englishbg Bulgarianzh-CN Chinese (Simplified)hr Croatiancs Czechda Danishnl Dutchfi Finnishfr Frenchde Germanel Greekiw Hebrewhi Hindiid Indonesianit Italianja Japaneseko Koreanmk Macedonianpl Polishpt Portuguesero Romanianru Russiansr Serbiansk Slovaksl Slovenianes Spanishsv Swedishth Thaitr Turkishvi Vietnamese

iCMLf Conversation: Highlights of the 24th John Goldman E-Conference - Clinical overview incl. Q&A Session

Jorge Cortes 2013

Expert:

Professor Jorge Cortes
Georgia Cancer Centre, Augusta (USA)

Meet-the-CML-Experts Q&A Session

Collage Apperley Saglio

Panel of experts:

Professor Jane Apperley
Imperial College London (UK)

Professor Giuseppe Saglio
University of Turin (Italy)

iCMLf Conversation: Treatment of CML patients after failure of 2 TKIs

  Andreas Hochhaus

Expert:

Professor Andreas Hochhaus
Director of the Department of Hematology and Medical Oncology
Jena University Hospital
(Germany)

iCMLf Conversation: CML Highlights of EHA 2022 - Biological and clinical overview

Collage Hughes Wolf

Experts:

Professor Timothy Hughes
SAHMRI / SA Pathology, University of Adelaide (Australia)

Professor Dominik Wolf
Department of Hematology and Oncology, Comprehensive Cancer Centre, Medical University Innsbruck (Austria)

iCMLf Conversation: Update on CML and COVID-19 management (in Spanish)

 

 


 Experts:

Collage Pavlovsky Moiraghi

 

  • Dr Carolina Pavlovsky, Fundaleu Hospital and Clinical Research Center Buenos Aires (Argentina)

  • Dr Beatriz Moiraghi, Hospital Ramos Mejía, Buenos Aires (Argentina)